Michael J. Fox Urges Drug Companies to Be More 'Proactive'

Monday, 7 May 2007 | 11:14 AM ET

Michael J. Fox's life changed in 1991, when the actor was diagnosed with Parkinson's disease. Since then, he's used his celebrity in the fight for potential treatments and cures. In an exclusive "Squawk Box" interview with CNBC's Mike Huckman, Fox urged the pharmaceutical and biotech industry to stop "repackaging the same thing" -- before time runs out for patients like him.

Michael J. Fox Pressures Biotechs
Michael J. Fox, who was diagnosed with Parkinson's disease in 1991, is turning up the heat on the biotech and drug industries. Mike Huckman, CNBC's pharmaceuticals reporter, has the story

Fox said one of the key prescriptions for Parkinson's is Sinamet, or generically, L-dopa, which has limited success in treating the degenerative disease -- and it's "been on the market for 40 years." Thus, the performer feels even more "frustration and urgency" at the perceived inertia in the research-to-market pipeline -- as it is "not a time-neutral situation" for sufferers.

Fox pointed out that he's "not assigning blame or castigating any individuals," but is merely imploring the industry to be more "proactive" in seeking new solutions.

  Price   Change %Change


Contact Squawk Box


    Get the best of CNBC in your inbox

    › Learn More
  • Showtimes

    Weekdays 6a ET
    Weekdays 13:00 CET
    Weekdays 18:00 SIN/HK
    Weekdays 20:00 SYD
    New Zealand
    Weekdays 22:00 NZ
  • Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.

  • Becky Quick is co-anchor of "Squawk Box," CNBC's signature morning program. She's also a columnist for Fortune.

  • Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.